July 29, 2014

CSRWire.com The Corporate Social Responsibility Newswire

news by category

Can Corporate Sustainability & Economic Growth Coexist?


We chatted with SAP, BSR, CDP and 232 communicators.

Generating over 1,300 tweets.

9,437,880 impressions

&

Engaging over 377,000 Twitter accounts.

See more Analytics!

&

Let's chat!

Reversing Perception, Creating Impact:

We Chat with MGM's Executive Team!

MGM executive team

Generating 5.6 million impressions.

Engaging over 270,000 Twitter accounts.

With over 650 tweets.

mgm

See more Analytics!

&

Let's talk!

#BaBf: What Does it Mean to Brew a Better Future?

We chat LIVE with

Heineken

Generating 6.2 million impressions.

Engaging almost 300,000 Twitter accounts.

With  146 communicators.

And almost 800 tweets.

Heineken sustainability goals

See more Analytics!

&

Learn more about our Twitter Chats!

When Corporate Citizenship Integrates with Business Strategy: In Conversation with

HP Living ProgressGenerating 7.2 million impressions.

Engaging almost 1.3 million Twitter accounts.

With 193 communicators.

And almost 800 tweets.

See more Analytics!

&

Let's chat!


What Does it Mean
to Compete to be
Best FOR the
World?

We chatted LIVE
with:

Badger Balm, Indigenous Designs

Generating 8.1 million impressions.

With 128 communicators.

And almost 900 tweets.

See more Analytics!

&

Let's chat!

CSR Press Release

New training manual for treatment of type 1 diabetes in children in developing countries

Submitted by: Novo Nordisk

Categories: Health & Wellness, Research, Reports & Publications

Posted: Oct 27, 2010 – 09:08 AM EST

 

BAGSVAERD, Denmark, Oct. 27 /CSRwire/ - In collaboration with the International Society for Pediatric and Adolescent Diabetes (ISPAD) Novo Nordisk has today launched a training manual specific to the diagnosis and treatment of diabetes care for children in developing countries. Unveiled on the opening day of the ISPAD Congress 'ISPAD 2010', which is currently taking place in Buenos Aires, this first edition of the manual is available for download at www.changingdiabetesaccess.com.

"We at Novo Nordisk are proud to have played a role in the development of this manual. It is a great privilege to be able to unveil the first edition at ISPAD 2010, where some of the world's most influential paediatric diabetes experts and healthcare professionals meet with a common purpose," says Dr Mapoko Ilondo, senior advisor, Global Health Partnerships, Novo Nordisk.

Childhood diabetes has a high mortality rate in developing countries, where life expectancy for a child with newly diagnosed type 1 diabetes is typically less than one year.

Novo Nordisk initiated the Changing Diabetes® in Children (CDiC) programme in 2006, due to the urgent need to improve the conditions for children with diabetes in the world's poorest countries, where access to insulin and monitoring tools as well as knowledgeable healthcare professionals are vital.

In developing countries, many children may either be misdiagnosed, be unable to properly manage the disease or even die before they can be diagnosed. According to the International Diabetes Federation (IDF), an estimated 480,000 children under the age of 15 live with type 1 diabetes worldwide and many of them in developing countries.

Approximately 76,000 children under 15 years develop diabetes each year. (IDF Diabetes Atlas, Fourth Edition, 2009).

For more information about Novo Nordisk, please visit: www.novonordisk.com.

For more information, please contact:

Tania Sabroe Media Relations Officer
Phone: (+45) 4443 5677

For more from this organization:

Novo Nordisk

 

Issuers of news releases and not csrwire are solely responsible for the accuracy of the content